V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007105 | 330003892 | 1.64 | 42.7 | Curative (C) | 2015-12-08 | 2015-12-08 | Rituximab (Maintenance) | N | N | 330007716 | RITUXIMAB |
| 330007106 | 330003892 | 1.68 | 68 | Neo-adjuvant (N) | null | 2013-03-05 | Cetuximab 7 day (Cycle 1) | N | null | 330007716 | CETUXIMAB |
| 330007107 | 330008112 | 1.78 | 74.6 | Neo-adjuvant (N) | null | 2016-03-24 | PAM x 2 post-surgery (cycles 3&4) | 2 | N | 330007719 | MAP |
| 330007108 | 330003902 | 1.66 | 93.2 | Neo-adjuvant (N) | 2016-10-01 | 2016-12-17 | Cetuximab 7 day (>Cycle 2) | N | null | 330007725 | CETUXIMAB |
| 330007109 | 330003902 | 1.69 | 64.7 | Palliative (P) | 2017-01-09 | 2017-01-23 | Carboplatin AUC 2 - 5 | N | N | 330007725 | CARBOPLATIN |
| 330007110 | 330003904 | 1.81 | null | Palliative (P) | 2015-07-15 | 2015-09-08 | Cetuximab 7 day (Cycle 1) | 02 | N | 330007730 | CETUXIMAB |
| 330007111 | 330003904 | 1.84 | 57.9 | null | 2017-07-18 | 2017-07-24 | Cetuximab 7 day (>Cycle 2) | 2 | N | 330007730 | CETUXIMAB |
| 330007112 | 330003906 | 1.61 | 85 | Neo-adjuvant (N) | 2016-01-27 | 2016-01-27 | Carboplatin AUC 6 - 10 | N | N | 330007739 | CARBOPLATIN |
| 330007113 | 330012378 | 1.6 | null | Curative (C) | 2014-07-09 | 2014-08-06 | Methotrexate High Dose (3g/m2) | 02 | null | 330007750 | METHOTREXATE HIGH DOSE |
| 330007114 | 330003908 | 1.61 | 92.4 | null | 2016-06-14 | 2016-07-10 | MAP | 02 | Y | 330007754 | MAP |
| 330007115 | 330003910 | 1.8 | null | Curative (C) | 2017-05-09 | 2017-05-11 | Rituximab (Maintenance) | N | N | 330007754 | RITUXIMAB |
| 330007116 | 330003910 | 1.64 | 69.2 | Adjuvant (A) | 2015-03-21 | 2015-04-10 | Docetaxel + Gemcitabine with GCSF | N | N | 330007754 | DOCETAXEL + GEMCITABINE |
| 330007117 | 330003911 | 1.6 | 60.5 | Palliative (P) | null | 2017-11-22 | Docetaxel+Gemcitabine (no prior RT) | N | N | 330007774 | DOCETAXEL + GEMCITABINE |
| 330007118 | 330003913 | 1.64 | 19.2 | Curative (C) | 2015-06-07 | 2015-06-14 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | 330007776 | MAP |
| 330007119 | 330003915 | null | 71.05 | null | 2016-05-27 | 2016-06-02 | CETUXIMAB | null | N | 330007779 | CETUXIMAB |
| 330007120 | 330003915 | 1.88 | 55.2 | Palliative (P) | 2013-05-12 | 2013-05-19 | Docetaxel + Gemcitabine (prior RT) | N | Y | 330007779 | DOCETAXEL + GEMCITABINE |
| 330007121 | 330012379 | 1.63 | 59.6 | Palliative (P) | null | 2017-02-16 | DOCETAXEL + GEMCITABINE | 02 | N | 330007788 | DOCETAXEL + GEMCITABINE |
| 330007122 | 330012379 | 1.72 | 57 | Neo-adjuvant (N) | null | 2015-10-02 | ETOPOSIDE + IFOSFAMIDE | 02 | N | 330007788 | ETOPOSIDE + IFOSFAMIDE |
| 330007123 | 330003918 | 1.65 | 87.35 | Neo-adjuvant (N) | 2014-07-15 | 2017-04-05 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | 330007804 | MAP |
| 330007124 | 330003919 | 1.76 | null | null | 2015-03-01 | 2015-03-07 | CETUXIMAB | null | null | 330007807 | CETUXIMAB |
| 330007125 | 330003920 | null | 70 | Palliative (P) | 2015-02-06 | 2015-02-07 | Docetaxel + Gemcitabine with GCSF | 02 | N | 330007812 | DOCETAXEL + GEMCITABINE |
| 330007128 | 330011674 | 1.8 | 75.9 | Neo-adjuvant (N) | 2016-05-16 | 2016-06-30 | Etoposide + Ifosfamide (3 days) | N | N | 330007831 | ETOPOSIDE + IFOSFAMIDE |
| 330007129 | 330003921 | 1.62 | 62.2 | Neo-adjuvant (N) | 2017-03-22 | 2017-04-03 | Carboplatin AUC 2 - 5 | 02 | null | 330007847 | CARBOPLATIN |
| 330007132 | 330003922 | null | 95.9 | Curative (C) | 2017-09-14 | 2018-02-21 | Docetaxel + Gemcitabine (prior RT) | 02 | Y | 330007855 | DOCETAXEL + GEMCITABINE |
| 330007133 | 330003922 | 1.8 | null | Palliative (P) | 2015-08-13 | 2015-10-27 | Carboplatin AUC 6 - 10 | null | null | 330007855 | CARBOPLATIN |
| 330007134 | 330003923 | 1.73 | 51 | Curative (C) | 2015-10-19 | 2015-11-16 | MAP | 02 | N | 330007871 | MAP |
| 330007135 | 330003923 | 1.64 | 122.2 | Neo-adjuvant (N) | 2017-06-17 | 2017-06-21 | PAM x 2 pre-surgery (cycles 1&2) | null | null | 330007871 | MAP |
| 330007136 | 330012381 | 1.65 | 95 | Palliative (P) | 2017-05-11 | 2017-06-04 | Cisplatin +Fluorouracil (2 wk) | N | N | 330007888 | CISPLATIN + FLUOROURACIL |
| 330007137 | 330003925 | 1.5 | 58.2 | Neo-adjuvant (N) | 2016-11-13 | 2016-11-18 | Cisplatin +Fluorouracil (3 wk) | N | N | 330007888 | CISPLATIN + FLUOROURACIL |
| 330007138 | 330003927 | 1.59 | 37.4 | Neo-adjuvant (N) | 2015-03-19 | 2015-03-20 | Docetaxel + Gemcitabine (prior RT) | N | N | 330007891 | DOCETAXEL + GEMCITABINE |
| 330007139 | 330003929 | 1.82 | 79.7 | null | 2016-07-05 | 2016-07-11 | OST Euramos 1 Closed Trial - M | N | N | 330007899 | METHOTREXATE HIGH DOSE |
| 330007140 | 330003932 | 1.62 | 107 | Curative (C) | 2017-06-10 | 2017-06-10 | CARBOPLATIN | N | N | 330007905 | CARBOPLATIN |
| 330007141 | 330003932 | 1.73 | null | Palliative (P) | 2019-04-09 | 2019-04-09 | Rituximab (Maintenance) | 02 | N | 330007905 | RITUXIMAB |
| 330007142 | 330003933 | 1.6 | 87.8 | Neo-adjuvant (N) | 2018-04-21 | 2018-04-21 | Etoposide + Ifosfamide (3 days) | 02 | N | 330007915 | ETOPOSIDE + IFOSFAMIDE |
| 330007143 | 330008134 | 1.58 | 58.3 | Curative (C) | 2017-10-03 | 2017-10-03 | Rituximab (Maintenance) | N | N | 330007924 | RITUXIMAB |
| 330007144 | 330003937 | 1.65 | 48.6 | Neo-adjuvant (N) | 2014-10-26 | 2015-05-15 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 330007926 | DOCETAXEL + GEMCITABINE |
| 330007145 | 330003937 | 1.93 | 54 | Neo-adjuvant (N) | 2014-10-11 | 2014-10-16 | Docetaxel + Gemcitabine (prior RT) | N | N | 330007926 | DOCETAXEL + GEMCITABINE |
| 330007146 | 330010416 | 1.63 | 24 | null | 2016-10-02 | 2016-10-03 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 330007962 | CISPLATIN + FLUOROURACIL |
| 330007147 | 330003938 | 1.68 | null | Neo-adjuvant (N) | 2016-06-20 | 2016-07-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 330007962 | CISPLATIN + FLUOROURACIL |
| 330007148 | 330003939 | 1.63 | 42 | Neo-adjuvant (N) | 2014-07-02 | 2014-07-13 | CISPLATIN + FLUOROURACIL | N | N | 330007971 | CISPLATIN + FLUOROURACIL |
| 330007150 | 330003947 | 1.66 | 60.5 | Curative (C) | 2015-12-20 | 2016-04-16 | Rituximab | 2 | N | 330007980 | RITUXIMAB |
| 330007151 | 330003947 | 1.69 | null | null | 2015-10-19 | 2015-10-19 | CETUXIMAB | null | null | 330007980 | CETUXIMAB |
| 330007152 | 330003948 | 1.64 | 81.4 | Curative (C) | 2014-07-22 | 2014-07-22 | Rituximab | 02 | N | 330007988 | RITUXIMAB |
| 330007153 | 330003949 | 1.55 | 52 | null | 2014-12-06 | 2014-12-18 | CETUXIMAB | 2 | N | 330007988 | CETUXIMAB |
| 330007154 | 330003951 | 1.7 | 54.45 | Palliative (P) | 2017-03-09 | 2017-04-14 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | 330008004 | DOCETAXEL + GEMCITABINE |
| 330007155 | 330008147 | null | 62.35 | Adjuvant (A) | 2017-01-06 | 2017-01-11 | CISPLATIN + FLUOROURACIL | N | Y | 330008007 | CISPLATIN + FLUOROURACIL |
| 330007156 | 330008147 | 1.6 | 77.35 | Curative (C) | 2016-08-28 | 2016-11-21 | CISPLATIN + FLUOROURACIL | N | N | 330008007 | CISPLATIN + FLUOROURACIL |
| 330007157 | 330008148 | 1.6 | 58 | Curative (C) | 2013-03-07 | 2013-04-13 | Rituximab | N | N | 330008011 | RITUXIMAB |
| 330007158 | 330011679 | null | null | Palliative (P) | 2016-06-20 | 2016-07-10 | Cetuximab 7 day (>Cycle 2) | 02 | null | 330008011 | CETUXIMAB |
| 330007159 | 330003953 | 1.73 | 101 | Curative (C) | 2017-03-25 | 2017-03-25 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | 330008012 | MAP |